Press release
COLLEEN CRABTREE VOLUNTEERS TO HOST LEUKEMIA AND LYMPHOMA SOCIETY FUNDRAISER
West Hollywood, CA - Comedic actress Colleen Crabtree, star of HBO’s U.S. Comedy Arts Festival winner "Closing Escrow," has volunteered to serve as celebrity “ball-caller” for West Hollywood’s Legendary Bingo fundraiser on October 17, 2007. The event will be held at Hamburger Mary’s, 8288 Santa Monica Blvd., at 9:00 p.m. Proceeds will benefit the Leukemia and Lymphoma Society’s Team In Training.Team In Training (www.teamintraining.org) provides endurance training to run or walk marathons and half marathons or participate in triathlons and century (100-mile) bike rides. In exchange for personalized coaching, participation in training clinics, and travel expenses to events, participants help raise money towards cures for blood cancers such as leukemia, lymphoma, and myeloma.
"I've witnessed the pain and uncertainty of this type of disease through my very close friends," says Crabtree. "I'm extremely honored to represent this cause."
Established in 1998, Legendary Bingo is a weekly fundraiser that has become a West Hollywood cultural landmark. Each week features a different charity. The event is led by actors Jeffrey Bowman ("Bingo-boy") and Scott Presley ("The Fabulous Belle Aire").
Past celebrity ball-callers include Courtney Cox, David Spade, Loni Anderson, and Ruth Buzzi.
###
For more information, or to interview Colleen Crabtree, contact Livia Squires at contact@squirespr.com or call (310) 273-4340.
For more information on Team In Training, visit www.teamintraining.org.
About Colleen Crabtree:
Colleen Crabtree is currently filming “Opposite Day,” in which she leads alongside Pauly Shore. She recently appeared on USA Network’s “Monk.” She began rehearsals this month with her husband, comedian Dan Rothenberg, on their autobiographical play, "Regretrosexual - The Love Story." It opens at the Hudson Guild Theatre in Los Angeles on February 7, 2008.
To view video demos of Colleen Crabtree’s work, visit www.myspace.com/colleencrabtree.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release COLLEEN CRABTREE VOLUNTEERS TO HOST LEUKEMIA AND LYMPHOMA SOCIETY FUNDRAISER here
News-ID: 30593 • Views: …
More Releases from Squires Public Relations for Colleen Crabtree
![COLLEEN CRABTREE STARS IN NEW FILM ‘CLOSING ESCROW’](https://cdn.open-pr.com/e/3/e31fd402507e12e8f220e49617cd5b4d_g.jpg)
COLLEEN CRABTREE STARS IN NEW FILM ‘CLOSING ESCROW’
Los Angeles, CA - Actress and comedian Colleen Crabtree will play the role of Mary in Magnolia Pictures’ new comedy, “Closing Escrow.” The film is directed by Armen Kaprelian. It opens Friday, August 24, 2007 at theaters in Los Angeles, San Francisco, Phoenix, Denver, and New York.
“Escrow” is the story of three quirky families seeking to buy their next home. Each has a reason for moving and a reason they…
More Releases for Leukemia
Pipeline Review, H2 2017 of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic …
"Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2017" The Report covers current Industries Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
. .
Description-
' …
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape.
Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the…
Acute Lymphoblastic Leukemia (ALL) Market grows with high incidence of acute lym …
Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called as lymphocytes in bone marrow. It is a malignant disease in which early precursor lymphoid cells proliferate and replace the normal hematopoietic cells of bone marrow. ALL is the most common type of cancer in children. There is overproduction of lymphoblasts in the bone marrow when a person suffers from ALL that continuously multiply, damaging the bone marrow…
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports.
GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to…
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth…